Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

Enterprise technology news and analysisGoogle launches Gemini in Chrome weeks after antitrust win, escalating AI browser wars The rollout positions Chrome as a productivity hub amid rising competition ...